Baldwin Wealth Partners’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-500
| Closed | -$6.15K | – | 808 |
|
|
2023
Q1 | $6.15K | Hold |
500
| – | – | ﹤0.01% | 662 |
|
|
2022
Q4 | $5.73K | Hold |
500
| – | – | ﹤0.01% | 649 |
|
|
2022
Q3 | $2K | Hold |
500
| – | – | ﹤0.01% | 627 |
|
|
2022
Q2 | $3K | Hold |
500
| – | – | ﹤0.01% | 642 |
|
|
2022
Q1 | $3K | Hold |
500
| – | – | ﹤0.01% | 637 |
|
|
2021
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 609 |
|
|
2021
Q3 | $2K | Hold |
500
| – | – | ﹤0.01% | 622 |
|
|
2021
Q2 | $3K | Hold |
500
| – | – | ﹤0.01% | 621 |
|
|
2021
Q1 | $3K | Hold |
500
| – | – | ﹤0.01% | 591 |
|
|
2020
Q4 | $3K | Hold |
500
| – | – | ﹤0.01% | 524 |
|
|
2020
Q3 | $2K | Hold |
500
| – | – | ﹤0.01% | 515 |
|
|
2020
Q2 | $2K | Hold |
500
| – | – | ﹤0.01% | 512 |
|
|
2020
Q1 | $1K | Hold |
500
| – | – | ﹤0.01% | 544 |
|
|
2019
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 528 |
|
|
2019
Q3 | $2K | Sell |
500
-136
| -21% | -$544 | ﹤0.01% | 503 |
|
|
2019
Q2 | $3K | Hold |
636
| – | – | ﹤0.01% | 491 |
|
|
2019
Q1 | $3K | Hold |
636
| – | – | ﹤0.01% | 489 |
|
|
2018
Q4 | $2K | Hold |
636
| – | – | ﹤0.01% | 490 |
|
|
2018
Q3 | $3K | Hold |
636
| – | – | ﹤0.01% | 501 |
|
|
2018
Q2 | $2K | Hold |
636
| – | – | ﹤0.01% | 501 |
|
|
2018
Q1 | $4K | Buy |
+636
| New | +$4K | ﹤0.01% | 462 |
|